Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!
$Meta Platforms, Inc.(META)$ is digesting a sharp post-earnings reaction near the $642–$648 zone after pulling back from its 52-week peak near $780. The stock is retesting its year-to-date baseline around $648, where buyers previously stepped in to halt downside momentum. Price action is trading below its 20-day and 50-day moving averages, but holding key structural support above the 200-day SMA. A daily close above immediate resistance at $676–$685 triggers a tactical rebound toward the $700 gap-fill area. I'm watching for a long entry on a volume bounce off $640, keeping a tight stop-loss strictly below $632 to guard against a deeper breakdown toward $600.
ARKK Investment Tracker position change: Decreased position in GeneDx Holdings by 3,660 shares, the number of shares held decreased 0.41% compared to the previous period and now represents 1.09% of the total position.
ARKK Investment Tracker position change: Increased position in Pacific Biosciences of California by 151,844 shares, the number of shares held increased 1.23% compared to the previous period and now represents 0.47% of the total position.
ARKK Investment Tracker position change: Decreased position in SoFi Technologies Inc. by 8,562 shares, the number of shares held decreased 0.41% compared to the previous period and now represents 0.55% of the total position.
ARKK Investment Tracker position change: Decreased position in Eli Lilly by 108 shares, the number of shares held decreased 0.4% compared to the previous period and now represents 0.6% of the total position.
ARKK Investment Tracker position change: Decreased position in X-Energy by 18,828 shares, the number of shares held decreased 0.41% compared to the previous period and now represents 0.88% of the total position.
$Meta Platforms, Inc.(META)$ is digesting a sharp post-earnings reaction near the $642–$648 zone after pulling back from its 52-week peak near $780. The stock is retesting its year-to-date baseline around $648, where buyers previously stepped in to halt downside momentum. Price action is trading below its 20-day and 50-day moving averages, but holding key structural support above the 200-day SMA. A daily close above immediate resistance at $676–$685 triggers a tactical rebound toward the $700 gap-fill area. I'm watching for a long entry on a volume bounce off $640, keeping a tight stop-loss strictly below $632 to guard against a deeper breakdown toward $600.
ARKK Investment Tracker position change: Increased position in Pacific Biosciences of California by 151,844 shares, the number of shares held increased 1.23% compared to the previous period and now represents 0.47% of the total position.
ARKK Investment Tracker position change: Decreased position in SoFi Technologies Inc. by 8,562 shares, the number of shares held decreased 0.41% compared to the previous period and now represents 0.55% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 594,439 shares, the number of shares held increased 5.62% compared to the previous period and now represents 1.15% of the total position.
ARKK Investment Tracker position change: Decreased position in Taiwan Semiconductor Manufacturing by 594 shares, the number of shares held decreased 0.41% compared to the previous period and now represents 1.11% of the total position.
ARKK Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 96,276 shares, the number of shares held decreased 0.41% compared to the previous period and now represents 1.51% of the total position.
ARKK Investment Tracker position change: Decreased position in GeneDx Holdings by 3,660 shares, the number of shares held decreased 0.41% compared to the previous period and now represents 1.09% of the total position.
ARKK Investment Tracker position change: Decreased position in Eli Lilly by 108 shares, the number of shares held decreased 0.4% compared to the previous period and now represents 0.6% of the total position.
ARKK Investment Tracker position change: Decreased position in X-Energy by 18,828 shares, the number of shares held decreased 0.41% compared to the previous period and now represents 0.88% of the total position.
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 734,520 shares, the number of shares held increased 5.02% compared to the previous period and now represents 2.7% of the total position.
ARKK Investment Tracker position change: Decreased position in Kratos Defense & Security Solutions by 6,744 shares, the number of shares held decreased 0.41% compared to the previous period and now represents 1.13% of the total position.
ARKG Investment Tracker position change: Increased position in Adaptive Biotechnologies Corp by 87,960 shares, the number of shares held increased 5.02% compared to the previous period and now represents 2.25% of the total position.
ARKK Investment Tracker position change: Decreased position in Palantir Technologies Inc. by 6,716 shares, the number of shares held decreased 0.78% compared to the previous period and now represents 3.06% of the total position.